HealthBeacon, partners with Innomar Strategies, to bring its smart sharps bin offering to Canada.
(DUBLIN, IE., TORONTO, ON. –November 14th, 2018) HealthBeacon announced today their partnership with Innomar Strategies to provide the HealthBeacon smart sharps bin and digital therapeutic platform to Canadian patients across the country.
HealthBeacon is a Dublin headquartered, digital therapeutic company that produces a smart sharps bin to track and drive medication adherence. Following their recent FDA clearance in the US, HealthBeacon has begun investing resources in the North American markets of the United States and Canada. Innomar Strategies, a part of AmerisourceBergen, is the leading patient support provider in the Canadian specialty biopharmaceutical market, helping patients navigate the complicated Canadian healthcare system, and providing support for their injections and infusions.
“We have seen great patient engagement with the HealthBeacon tool in Ireland. It has been instrumental in aiding us in identifying patients that need assistance, and helping drive adherence to their medication. I’m delighted to see they are making HealthBeacon available in Canada.” – Dr. Trevor Duffy, Rheumatologist
HealthBeacon began operations in Canada with the opening of their Montreal office in December 2016. HealthBeacon CEO, Jim Joyce commented, “The Canadian market is a large market, both geographically and in terms of patients who could benefit from our technology. The signing of this partnership is a major milestone in making our technology accessible to the Canadian market.”
As an industry leader, Innomar deeply understands the patient journey. A core focus is delivering best-in-class care and education through patient services to monitor adherence and ensure optimal outcomes.
“We look forward to partnering with HealthBeacon as they move into the Canadian market. Our focus is on patient care, and having a tool to track and facilitate medication adherence brings value to patient care across Canada,” says Amar Pabla, Vice President Nursing, Clinics and Pharmacovigilance.
“HealthBeacon are a fantastic example of Irish innovation. This partnership is testimony to the deepening links between Irish and Canadian healthcare. As the government agency driving the growth of Irish businesses internationally, we at Enterprise Ireland look forward to seeing HealthBeacon support Innomar Strategies in its mission to advance patient support across Canada.” – Neil Cooney, Country Manager Canada, Enterprise Ireland
HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. The HealthBeacon is a smart sharps bin for patients who self-inject medications at home. It is digitally connected and programmed with a patient’s personal medication schedule, and uses customized reminders to help them start and stay on track with medication. The company is headquartered in Dublin, Ireland and has offices in the US and in Canada. Learn more at www.healthbeacon.com
About Innomar Strategies
Innomar Strategies, a part of AmerisourceBergen, is the leading patient support provider in the Canadian specialty biopharmaceutical market. We deliver end-to-end commercialization solutions to improve product access, increase supply chain efficiency and enhance patient care. Strategic consulting, patient support programs, nursing and clinical services, and specialty pharmacy and logistics are just a few of our key areas of specialization. We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment tobest-in-class care, Innomar Strategies helps navigate the patient journey to optimize health outcomes. Visit us at www.innomarstrategies.com.